Sajulga, Jana Mae .

HRN: 24-35-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2024
CEFUROXIME 1.5GM (VIAL)
01/12/2024
01/18/2024
IV
1.5g
Q8
LTCS +iud
Waiting Final Action 
01/12/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/12/2024
01/18/2024
IV
500mg
Q8
LTCS
Waiting Final Action 
01/13/2024
CEFUROXIME 500MG (TAB)
01/13/2024
01/19/2024
PO
500mg
BID
Ltcs
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: